Veterinary Practice Letter of Intent in 2026: The Two Documents That Decide Your Deal

Key takeaways

• Two documents decide your deal: the letter of intent (LOI), which locks structure, price, and exclusivity, and the definitive purchase agreement, which allocates the risk. Almost everything that matters to your after-sale life is settled in one of the two.
• An LOI is mostly non-binding on price but binding on exclusivity. The day you sign exclusivity is the day your leverage drops to its lowest point of the entire process.
• Fight for the economics in the LOI — structure, price, cash at close, earnout and rollover framework — while competing bidders are still at the table. Save the reps-and-warranties, escrow, and non-compete fights for the purchase agreement.
• The working capital adjustment and the escrow are where a clean-looking number quietly loses 3 to 10 percent after the handshake, if nobody is watching the definitions.
• Competitive tension before the LOI is the one thing that protects every term downstream. Without it, you are negotiating both documents from a position of one.

A vet I’d come to know over a couple of years forwarded me a letter of intent one evening with a single line above it: “This looks great, right?” The headline number was strong. The buyer was a well-known financial buyer, the kind most owners would be flattered to hear from.

On the surface it was exactly the offer he’d been hoping for.

I read the four pages twice. The price was fine.

What worried me was everything around it. The exclusivity ran 90 days with an automatic extension.

The structure was left vague. The earnout language pointed at targets that hadn’t been defined yet.

He was about to sign away his entire negotiating position to lock in a number that, as written, the buyer could still move.

That is the conversation this article is about. Not whether the headline is good, but whether the two documents that actually govern your sale are working for you or against you.

There are only two of them. Get them right and the deal you signed is the deal you get.

Get them wrong and the number on page one slowly drifts away from you over the months that follow.

This is general information, not legal advice, and every owner should have their own M&A attorney review the specific terms of any document before signing. What I can give you is the view from the other side of hundreds of these deals: what each document locks in, what’s still negotiable, and exactly where your leverage lives so you spend it where it counts.

The two documents, and why the order matters

In a veterinary practice sale there are two documents that decide the outcome. The first is the letter of intent — a mostly non-binding outline that sets the headline terms before anyone spends real money on lawyers.

The second is the definitive purchase agreement — the long, fully binding contract you sign at closing that fills in all the legal machinery the LOI left out.

Here is the short version, then the rest of the article unpacks it. The LOI locks the economics: whether the deal is an asset sale or a stock sale, the price, how the price is paid, and the exclusivity period.

The purchase agreement locks the risk: the seller’s representations and warranties, the working capital adjustment, the indemnification and escrow, and the non-compete. The seller’s leverage peaks at the LOI stage, before exclusivity is granted, and drops sharply the moment it’s signed.

That sequence is the whole game. Most owners treat the LOI as a formality and save their energy for the “real” contract.

They have it backwards. By the time you reach the purchase agreement, you’ve usually already signed away the competitive tension that would have given you the strength to negotiate it.

The terms you fail to pin down in the LOI don’t disappear. They come back in the definitive drafting, and they come back when you have no other bidder to walk to.

What a letter of intent actually locks in

A letter of intent isn’t a contract, and it isn’t quite an offer. It’s closer to a written agreement to explore a purchase on a defined set of terms.

As dvm360 puts it in its coverage of practice sales, the LOI describes the basic terms of the deal — the purchase price, the deal structure, the form and timing of payment, the assets and liabilities being transferred or kept, and the management and employment terms after closing.

Most of that is non-binding. But two parts almost always bind, and they’re the two parts that matter most to your position.

The binding parts: confidentiality and exclusivity

The first binding piece is confidentiality. You agree not to disclose the discussions or the terms.

That one is routine and rarely a problem.

The second binding piece is exclusivity, also called a no-shop — a clause that bars you from talking to, negotiating with, or accepting an offer from any other buyer for a fixed window while the chosen buyer runs diligence. This is the consequential one.

Today’s Veterinary Business, in its plain-language walk-through of practice sale documents, notes that the seller’s obligation not to entertain other offers until the LOI expires is one of the few genuinely enforceable parts of the document.

The window usually runs 60 to 90 days. For those weeks, you have exactly one buyer, and that buyer knows it.

The non-binding parts: price, structure, payment

Everything economic in the LOI is generally non-binding. The price is a number both sides expect to honor but neither is legally locked to.

The structure, the payment split, the earnout sketch, all of it is subject to the definitive agreement.

That cuts in a direction owners don’t expect. A non-binding price does not protect the seller.

It protects the buyer, who can revisit the number during diligence. What it does for the seller is set an anchor and, more importantly, set the moment you stop shopping.

So the value of the LOI to a seller isn’t that it locks the buyer in. It’s that it’s the last document you negotiate while you still have alternatives.

The single most important table in this article

Here’s how I lay it out for an owner over dinner. Two documents, what each one locks, what stays negotiable, and where your leverage sits at each stage.

	Letter of intent (LOI)	Definitive purchase agreement (usually an APA)
When you sign it	Early, before diligence	At closing, after diligence
Binding?	Mostly non-binding (exclusivity + confidentiality bind)	Fully binding
What it locks	Deal structure (asset vs stock), price, payment split (cash / earnout / rollover / note), exclusivity window	Reps and warranties, working capital adjustment, indemnification and escrow, non-compete, closing conditions
What stays negotiable after	Almost every economic term reopens in the APA	Nothing — this is the final word
Where your leverage is	At its peak, IF multiple buyers are still competing	Largely spent, unless your competitive process is still credible
What to fight for here	Structure, price, cash-at-close %, earnout/rollover framework, short exclusivity	Reps scope and survival, escrow size and duration, indemnity caps, working capital target, non-compete limits

Read the bottom two rows again. The terms with the highest dollar impact on your life — the price, the structure, the share of the deal you actually receive in cash — are decided in the column where your leverage is highest.

The terms that decide how much of that number you keep through risk allocation are decided in the column where your leverage is mostly gone. That asymmetry is why the order of operations matters so much.

Wondering what your practice would actually clear before you ever see an LOI? Get a Free Practice Value Estimate — we’ll normalize your numbers, identify the right buyer pool, and show you the range a competitive process would target. No upfront cost, no obligation.

Why the LOI is where your leverage peaks

Walk through it from the buyer’s chair for a second. Before you sign an LOI, the buyer is one of several.

They don’t know what the others are offering. They don’t know whether you’ll pick them.

To get picked, they have to put their best credible number on the table and keep the terms attractive.

The moment you sign exclusivity, all of that reverses. Now the buyer is the only one in the room, and they have 60 to 90 days of contractual quiet to find reasons the number should come down.

The other bidders have moved on with their year. Your walk-away alternative just evaporated.

This is the pattern I see most often when an owner comes to me after the fact. The deal didn’t fall apart at the LOI.

It eroded after it. A diligence finding here, a working capital quibble there, a reps-and-warranties package that got steadily more buyer-friendly as the weeks passed, because the seller had nothing left to push back with.

I’ve watched this play out enough times that I stopped calling it a risk and started calling it a rule. The terms you don’t lock before exclusivity are the terms you negotiate from a position of one.

So the leverage you have at the LOI isn’t something to save for later. There is no later.

The LOI is the high-water mark, and a seller’s job is to get as much settled at that mark as the buyer will agree to before the rope goes up.

What to actually settle in the LOI

Given that the LOI is your strongest moment, here’s what belongs in it rather than left for the purchase agreement.

Deal structure: asset sale versus stock sale

The structure determines a great deal about your taxes and your risk, and it should be named in the LOI, not deferred. Most veterinary practice sales are structured as an asset sale — the buyer purchases the practice’s assets and assumes only specified liabilities, rather than buying the legal entity itself.

The alternative is a stock sale (or, for an LLC, a membership interest sale), where the buyer takes the whole entity, the good and the bad.

Buyers usually prefer asset deals because they get a cleaner liability picture and better tax treatment. Sellers often prefer stock deals for the opposite reasons.

This is a genuine negotiation with real money on both sides, and the structure interacts heavily with your tax outcome. For the tax mechanics specifically, see our guide to the tax consequences of selling a veterinary practice.

The point for the LOI is simple: name the structure, because leaving it vague hands the choice to whoever has more leverage during the definitive drafting, and after exclusivity that’s the buyer.

Price and the payment split

The headline price gets all the attention, but the split is where the real money lives. A modern PE-backed offer rarely pays the full number in cash on closing day.

It typically breaks into four pieces: cash at close, earnout — a portion paid later only if the practice hits agreed performance targets — rollover equity — keeping a slice of ownership in the new entity instead of taking all cash — and sometimes a seller note.

The full mechanics of those four components, and how much of the headline each one usually represents, are the subject of our guide to how much private equity is paying for veterinary practices. For the LOI, the move is to pin down the cash-at-close percentage and the framework for the rest, in writing, while you still have competing bids to hold the buyer honest.

A headline number with the split left to “good faith” is a number that can quietly shrink.

The earnout and rollover framework

You won’t fully draft the earnout in the LOI, but you should frame it. What metric drives it — revenue, EBITDA, or a production figure?

Over what period? Who controls the operational decisions that determine whether the targets get hit?

That last question is the one owners miss. An earnout tied to EBITDA targets, controlled by a buyer who sets the staffing, pricing, and overhead after closing, is an earnout the seller doesn’t really control.

Frame the protections in the LOI. By the purchase agreement, the buyer has every reason to make those protections vaguer, not tighter.

A short, conditioned exclusivity period

Since exclusivity is the thing you’re giving up, give as little as you can. Aim for a window in the 30-to-60-day range rather than 90, push back on automatic extensions, and tie any extension to the buyer demonstrating good-faith diligence progress.

The shorter and more conditioned the no-shop, the faster you get your leverage back if the buyer starts to drift.

The definitive purchase agreement: where the risk lives

Once the LOI is signed and diligence runs, the lawyers draft the definitive agreement. In a veterinary deal this is almost always an asset purchase agreement (APA) — the long contract that transfers the practice’s assets and spells out every obligation, condition, and protection in binding detail.

As Today’s Veterinary Business notes, the purchase agreement incorporates and then supersedes the LOI, while adding many provisions the LOI never touched.

This document is where the economics you settled get converted into risk allocation. Four sections matter most to a seller, and none of them is the price.

Representations and warranties

Representations and warranties are the seller’s written factual statements about the practice — that the financials are accurate, the veterinary and DEA licenses are current, the equipment is owned free of liens, there’s no undisclosed litigation or regulatory action, the tax filings are in order. If one of these turns out to be false after closing, the buyer can bring a claim against the seller.

The negotiation here runs along three lines. How broad are the statements?

How long do they survive after closing, six months, a year, two? And what dollar caps limit the seller’s exposure if something’s wrong?

A seller wants narrower reps, shorter survival, and lower caps. A buyer wants the reverse.

This is one of the most heavily negotiated parts of any APA, and it’s where having your own experienced M&A counsel earns their fee many times over.

The working capital adjustment

The working capital adjustment is a post-closing true-up that compares the working capital delivered with the practice against an agreed target, then moves the final price up or down for the gap. In a veterinary practice, working capital is mostly drug and supply inventory plus receivables, net of payables.

The buyer wants the practice handed over stocked and funded to run normally on day one, so they don’t have to inject cash the morning after closing. Fair enough.

The trap for sellers is in two places: how the target is set, and how inventory gets counted and valued. An unrealistically high target, or an aggressive method for valuing expired or slow-moving inventory, quietly claws back part of the price you thought you’d locked.

This is one of the most common places a clean-looking deal loses real dollars after the handshake, and it’s almost invisible unless someone on your side is watching the definitions.

Indemnification and escrow

Indemnification is the buyer’s recovery mechanism if a seller statement proves wrong, and escrow is a portion of the price held back by a third party for a set period to cover any such claims before the rest is released to the seller.

Historically a chunk of the purchase price, often something like 10 percent, sat in escrow for a year or more. That’s changing.

On larger middle-market deals, buyers and sellers increasingly use representation and warranty insurance — a policy that shifts the risk of a breached representation onto an insurer instead of the seller’s escrow. Holland & Knight notes that this insurance lets the parties substantially reduce or even eliminate the indemnification escrow, because the buyer looks to the policy rather than to held-back seller money.

For a seller, a smaller escrow means more of your money in your account at closing, so whether insurance is on the table is worth raising early.

The non-compete

A buyer paying a premium for goodwill will require the selling owner to sign a non-compete — an agreement not to open or work at a competing practice within a defined radius for a defined number of years. This is standard and reasonable.

The buyer is paying for the patient relationships you built, and they don’t want you reopening across town and taking them back.

What’s worth knowing is that the legal ground here shifted recently. Holland & Knight’s analysis of the federal and state action on non-competes points out that even as employment non-competes get restricted or banned in various states, non-competes tied to the sale of a practice generally remain enforceable, often where the duration stays under 5 years.

The terms to negotiate are the radius, the duration, the precise definition of competing activity, and carve-outs, for example for occasional relief work or teaching. State law varies a great deal here, which is one more reason to have your own attorney review the non-compete against the rules where you practice.

The thread that runs through both documents

Step back from the clauses and there’s a single force that determines how favorable both documents turn out, and it isn’t your lawyer’s drafting skill, valuable as that is. It’s whether there’s competition behind you when you negotiate.

A buyer drafting a reps-and-warranties package for a seller who has no other option will draft it one way. The same buyer, drafting for a seller who could credibly walk to another bidder this week, drafts it another way entirely.

The presence of an alternative changes the working capital target, the escrow size, the survival periods, the earnout protections, all of it. Not because the buyer is acting in bad faith, but because every buyer rationally calibrates terms to the seller’s leverage, the same way you would in their position.

This is exactly why the process you run before the LOI shapes everything that comes after it. At Transitions Elite we run that process through what we call the Elite Selling System.

We hand-select and vet every buyer who gets to bid on a practice, the way a doorman with a velvet rope lets in only the right people, then run a private competitive window inside that vetted group. The point isn’t only to lift the headline number, though it does that.

It’s to carry real competitive tension all the way into the documents, so the seller is negotiating the LOI and the purchase agreement with leverage instead of without it.

Across the deals we’ve closed over the past four-plus years, the difference between a seller who entered the LOI with live competition and one who’d already narrowed to a single buyer shows up everywhere, not just in price. It shows up in shorter escrows, tighter earnout protections, cleaner working capital targets, and more reasonable non-competes.

The competition doesn’t end when the LOI is signed if the buyer still believes it’s real.

A pattern I see again and again

The most common version of the story that brings an owner to me looks like this. A strong, unsolicited offer arrives from a single financial buyer.

The number is genuinely good, better than the owner expected. The LOI lands with a 90-day exclusivity and a request to move fast.

The owner, understandably, doesn’t want to slow down a great offer by inviting competition or by negotiating hard on a document that’s “mostly non-binding anyway.” They sign. And then, over the exclusivity window, the experience changes.

A diligence finding shaves the price. The working capital target turns out to be higher than the practice naturally carries.

The reps package the lawyers send over is broad and long-surviving. None of it is dramatic on its own.

Together it’s real money, and by then there’s no leverage left to resist it.

The owners who avoid this aren’t the ones with the toughest lawyers, though good counsel matters. They’re the ones who established competition before the LOI and settled the economics while that competition was live.

Same practice, same buyer pool, often the same headline number. The difference is what survived from page one to closing day, and that difference traces straight back to whether anyone else was still at the table when the rope went up.

What to do next

If you take one thing from all of this, take the sequence. The economics are decided in the LOI, the risk is allocated in the purchase agreement, and your leverage for both is set before you grant exclusivity.

The owners who keep the most of their headline number are the ones who treat the LOI as the most important document they’ll sign, not the least.

There are two moves that mostly determine the outcome. The first is to know your real, defensible value before any buyer’s LOI anchors you to theirs, so you can judge an offer against the market rather than against your hopes.

The whole arc from preparation to closing, including how the documents fit the larger process, is laid out in our guide to selling a veterinary practice.

The second is to make sure there’s genuine competition behind you when you negotiate both documents. That single factor does more to protect your terms than any clause your attorney can draft after the fact, because it changes what the buyer is willing to agree to in the first place.

Get a Free Practice Value Estimate →

We pull your numbers, build a defensible normalized value, identify the right pool of qualified buyers for your specific profile and geography, and run the competitive process that gives you leverage in both the LOI and the purchase agreement. The estimate is free and there’s no obligation to engage further.

The Transitions Elite engagement model is success-based, with no upfront fees and no retainer. We only get paid when a deal closes, and only out of the value our process delivers above what you would have realized on your own.

And we work alongside your own M&A attorney, whose job is the legal terms, while ours is the leverage that makes those terms negotiable.

---

Further reading

These are the related TE resources I’d point any vet considering a sale toward. Each goes deep on one dimension of the decision.

• How much private equity is paying for veterinary practices — the four components of any PE-backed offer and why the headline rarely equals the cash check.
• The tax consequences of selling a veterinary practice — asset versus stock structure from the tax lens, and how the choice changes your after-sale check.
• How to sell a veterinary practice — the full process from advisor engagement to closing, with the documents in their proper sequence.
• Veterinary practice EBITDA multiples — what practices actually sell for in 2026 and what moves the multiple.
• About Transitions Elite — the team, the methodology, and the firm’s track record.

Frequently asked questions

What is a veterinary practice letter of intent?

A veterinary practice letter of intent (LOI) is a mostly non-binding document that sets the headline terms of a sale before the parties spend money drafting the definitive agreement. It locks the deal structure (asset sale versus stock sale), the price and how it’s paid (cash at close, earnout, rollover equity, seller note), and the exclusivity period.

Most of an LOI is non-binding, but two parts almost always bind: confidentiality and exclusivity. Signing exclusivity ends your ability to talk to other buyers, which is why the LOI is where a seller’s leverage peaks and where it should be exercised before signing, not after.

Is a letter of intent legally binding in a veterinary practice sale?

Mostly no, with two important exceptions. The economic terms of an LOI — price, structure, payment — are generally non-binding and are renegotiated through the definitive purchase agreement.

But the confidentiality and exclusivity (no-shop) provisions are almost always written to be binding and enforceable. So an LOI doesn’t lock the buyer into the price, but it does lock the seller out of the market for the exclusivity window, typically 60 to 90 days.

Always have your own M&A attorney review which clauses are binding before you sign.

What is the difference between an LOI and a purchase agreement?

The letter of intent is the short, mostly non-binding outline signed early; the definitive purchase agreement is the long, fully binding contract signed at closing. The LOI sets the headline terms (price, structure, exclusivity).

The purchase agreement, usually an asset purchase agreement in a veterinary deal, fills in the legal machinery: representations and warranties, the working capital adjustment, indemnification and escrow, and the non-compete. The purchase agreement supersedes the LOI, so any economic term the seller didn’t pin down in the LOI is fully back in play during the definitive drafting.

What should a seller negotiate in a veterinary practice LOI versus the purchase agreement?

At the LOI stage, fight for the economic terms while you still have competing bidders: the deal structure (asset versus stock), the price, the cash-at-close percentage, the earnout and rollover framework, and a short exclusivity period with clear conditions. At the purchase agreement stage, the fights shift to risk allocation: the scope and survival of representations and warranties, the size and duration of the escrow, the indemnification caps, the working capital target, and the geographic and time limits of the non-compete.

Your leverage is highest before you grant exclusivity, so the LOI is where the most valuable terms should be settled.

What is an exclusivity or no-shop period in a practice sale?

Exclusivity, also called a no-shop period, is a binding LOI provision that bars the seller from soliciting, negotiating with, or accepting offers from any other buyer for a fixed window while the chosen buyer completes due diligence. The window typically runs 60 to 90 days.

It’s the single most consequential thing a seller gives up in the LOI, because it removes all competitive tension from the rest of the process. The way to protect against a price walk-down during exclusivity is to keep the period short, tie any extension to the buyer’s good-faith progress, and only sign exclusivity after a competitive process has already established the price.

What are representations and warranties in a veterinary practice purchase agreement?

Representations and warranties are the seller’s written factual statements about the practice: that the financial statements are accurate, the veterinary and DEA licenses are current, the equipment is owned free of liens, and there’s no undisclosed litigation or regulatory action. If one proves false after closing, the buyer can bring an indemnification claim.

The negotiation centers on how broad the statements are, how long they survive after closing, and what dollar caps limit the seller’s exposure. On larger deals, representation and warranty insurance is increasingly used to shift much of that risk to an insurer and shrink the escrow the seller leaves behind.

What is a working capital adjustment in a veterinary practice sale?

A working capital adjustment is a post-closing true-up. The parties set a target level of working capital — mainly drug and supply inventory plus receivables, net of payables — that the practice should carry on closing day.

After closing, the actual delivered working capital is measured against that target, and the final price moves up or down for the difference. It exists so the buyer receives a practice stocked and funded to run normally on day one.

The two things that decide whether it helps or hurts the seller are how the target is set and how inventory is counted and valued.

Does a non-compete apply when I sell my veterinary practice?

Almost always, yes. A buyer paying a premium for a practice will require the selling owner to agree not to open or work at a competing practice within a defined radius for a defined number of years.

Non-competes signed in connection with the sale of a practice are generally enforceable even in states that have restricted or banned employment non-competes, provided the duration is reasonable (many proposals draw the line at under 5 years). The terms worth negotiating are the radius, the duration, the definition of competing activity, and any carve-outs for relief work or teaching.

Have your own attorney review the non-compete against your state’s current law.

---

Sources

Veterinary practice sale process and deal documents

1. dvm360. “8 essential steps in a veterinary practice sale.” dvm360.com
2. dvm360. “When it comes to buying a veterinary practice, consider a proposal.” dvm360.com
3. Today’s Veterinary Business. “Seal the Deal.” todaysveterinarybusiness.com
4. Today’s Veterinary Business. “Navigating a Corporate Takeover: Legal Lingo.” todaysveterinarybusiness.com
5. Today’s Veterinary Business. “An Examination You’ll Never Forget” (due diligence). todaysveterinarybusiness.com
6. AAHA. “Unlocking success: A guide to selling your veterinary practice to a consolidator.” aaha.org

Legal and deal-structure analysis

7. Holland & Knight. “Representation and Warranty Insurance in Healthcare Provider Deals: What You Need To Know.” hklaw.com
8. Holland & Knight. “FTC Bans Non-Competes: Takeaways and Action Items for Healthcare Provider CEOs and Investors.” hklaw.com
9. Holland & Knight. “A Year-End Report for Healthcare Antitrust and What to Expect Later in 2025.” hklaw.com
10. Alston & Bird. “Equity Rollovers.” alston.com
11. Alston & Bird. “Expanded California Law Targets Private Equity Deals in Health Care Sector.” 2025. alston.com

Market and M&A research

12. Capstone Partners. “Merger and Acquisition Outlook 2026.” capstonepartners.com
13. Capstone Partners. “Middle Market Private Equity Index — H1 2025.” capstonepartners.com
14. Dechert LLP. “Top Private Equity Trends and Outlook for 2025.” dechert.com
15. U.S. Securities and Exchange Commission (EDGAR). Asset purchase agreement filings, healthcare sector, 2025. sec.gov